Fresh data backs Amplia push against pancreatic, ovarian cancer
--------------------------------------------------------------------
Source: The Age
Published: 2026-07-31 13:15 UTC+10:00
Section: Business / Companies
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Drugs, Business & Economy
--------------------------------------------------------------------
Snippet:
Amplia Therapeutics has received encouraging lab results which highlighted the use of its lead drug narmafotinib, saying it can attack several of the nastier features that make the cancer so hard to treat.
--------------------------------------------------------------------